Abbott Laboratories (ABT)

100.76
+1.30(+1.31%)
  • Volume:
    897
  • Bid/Ask:
    100.52/100.76
  • Day's Range:
    99.37 - 100.76

ABT Overview

Prev. Close
99.46
Day's Range
99.37-100.76
Revenue
-
Open
99.39
52 wk Range
91-126
EPS
-
Volume
897
Market Cap
175.25B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,364
P/E Ratio
-
Beta
-
1-Year Change
-15.5%
Shares Outstanding
1,743,573,777
Next Earnings Date
Jan 25, 2023
What is your sentiment on Abbott Labs?
or
Vote to see community's results!

Abbott Laboratories News

Abbott Laboratories Analysis

Abbott Laboratories Company Profile

Abbott Laboratories Company Profile

  • Type:Equity
  • Market:Germany
  • ISIN:US0028241000
  • WKN:850103

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyBuySellNeutral
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellSell
  • Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals
    0
    • super boom
      0
      • super boom
        0
        • Boom!!
          1
          • its coiled like a snake it's ready to spring
            2
            • best time to buy ABT!
              2
              • Any idea what is the bottom?
                0
                • 106 but this is long term
                  1
                • Thank you.. Hope it will holds and does not drop below $100
                  0
              • excellent time to buy!!! good company and long run
                1
                • It is time to buy! This is extra money, new business created by Covid. Icing on the cake.
                  2
                  • buy now! i think?
                    1